CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- S-8 POS Other Post-effective Amendment
- POS AM Other Post-effective Amendment for Registration Statement
- 8-K12B Other 8-K12B
- POS AM Other Post-effective Amendment for Registration Statement
- 8-K Event Material agreement
- 8-K Event Other events
- 4 Option exercise Director acquired 4,373 shares (option exercise)
- 4 Option exercise Director acquired 4,373 shares (option exercise)
- 4 Option exercise Director acquired 4,373 shares (option exercise)
- 4 Option exercise Director acquired 4,373 shares (option exercise)
- 4 Option exercise Director acquired 4,373 shares (option exercise)
- 4 Option exercise Director acquired 4,373 shares (option exercise)
- 4 Grant or award Director acquired 12,692 shares (grant or award)
- 8-K Event Shareholder vote results
- DEFA14A Proxy Proxy Materials
- 4 Option exercise Director acquired 747 shares (option exercise)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 509 shares (to pay taxes)
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
Page 17 of 39 · 778 filings